Explore
Validate
Learn
Western blot
ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN967520 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fas Ligand (TNF Superfamily, Member 6) (FASL) antibody
- Antibody type
- Monoclonal
- Antigen
- Recombinant Human FasL
- Description
- Purified from tissue culture supernatant or ascites by affinity chromatography.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- G247-4
- Vial size
- 0.1 mg
- Concentration
- 0.5 mg/ml
- Storage
- 4°C
Submitted references Requirement of cysteine-rich repeats of the Fas receptor for binding by the Fas ligand.
The role of FasL-induced apoptosis in immune privilege.
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis.
Separate domains of the human fas ligand dictate self-association and receptor binding.
Expression of the functional soluble form of human fas ligand in activated lymphocytes.
Metalloproteinase-mediated release of human Fas ligand.
Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
Orlinick JR, Vaishnaw A, Elkon KB, Chao MV
The Journal of biological chemistry 1997 Nov 14;272(46):28889-94
The Journal of biological chemistry 1997 Nov 14;272(46):28889-94
The role of FasL-induced apoptosis in immune privilege.
Griffith TS, Ferguson TA
Immunology today 1997 May;18(5):240-4
Immunology today 1997 May;18(5):240-4
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis.
Sträter J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A, Krammer PH, Möller P
Gastroenterology 1997 Jul;113(1):160-7
Gastroenterology 1997 Jul;113(1):160-7
Separate domains of the human fas ligand dictate self-association and receptor binding.
Orlinick JR, Elkon KB, Chao MV
The Journal of biological chemistry 1997 Dec 19;272(51):32221-9
The Journal of biological chemistry 1997 Dec 19;272(51):32221-9
Expression of the functional soluble form of human fas ligand in activated lymphocytes.
Tanaka M, Suda T, Takahashi T, Nagata S
The EMBO journal 1995 Mar 15;14(6):1129-35
The EMBO journal 1995 Mar 15;14(6):1129-35
Metalloproteinase-mediated release of human Fas ligand.
Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H
The Journal of experimental medicine 1995 Dec 1;182(6):1777-83
The Journal of experimental medicine 1995 Dec 1;182(6):1777-83
Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S
Cell 1994 Mar 25;76(6):969-76
Cell 1994 Mar 25;76(6):969-76
No comments: Submit comment
No validations: Submit validation data